Relationship between the quantitative morphometry and the clinical response to alpha adrenergic blocker in benign prostatic hyperplasia

Japanese Journal of Urology

Volumn 87, Issue 3, 1996, Pages 695-701

  Sakai, Seiichi ^a   Shimazaki, Jun ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

alpha adrenergic blocker; benign prostatic hyperplasia; morphometry

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; PROSTATE SPECIFIC ANTIGEN; TAMSULOSIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; HUMAN; IMAGE ANALYSIS; MALE; MICTURITION; MORPHOMETRICS; PROSTATE HYPERTROPHY; RESIDUAL URINE; SMOOTH MUSCLE; TRANSURETHRAL RESECTION;

EID: 0029916958     PISSN: 00215287     EISSN: None     Source Type: Journal    
DOI: 10.5980/jpnjurol1989.87.695     Document Type: Article

References (34)

1. Rohr, H.P. and Bartsch, G.: Human benign prostatic hyperplasia: A stromal disease ? Urology, 16, 625-633, 1980.
2. Bartsch, G., Müller, H.R., Oberholzer, M. and Rohr, H.P.: Light microscopic stereological analysis of the normal prostate and of benign prostatic hyperplasia. J. Urol., 122, 487-491, 1979.
3. 1 adrenoceptors using radioligand receptor binding on slide-mounted tissue section. J. Urol., 150, 2002-2006, 1993.
4. 1 adrenoceptors in human prostate : Characterization and alteration in benign prostatic hypertrophy. J. Pharm. Exp. Ther., 242, 326-330, 1987.
5. Barry, M.J., Fowler, F.J. Jr., O'Leary, M.P., Bruskewitz, R.C., Holtgrewe, H.L., Mebust, W. K., Cockett, A.T.K. and The Measurement Committee of the American Urological Association: The American Urological Association symptom index for benign prostatic hyperplasia. J. Urol., 148, 1549-1557, 1992.
6. Raz, S., Zeigler, M. and Caine, M.: Pharmacological receptors in the prostate. Br. J. Urol., 45, 663-667, 1973.
7. Caine, M., Pfau, A. and Perlberg, S.: The use of alpha-adrenergic blockers in benign prostatic obstruction. Br. J. Urol., 48, 255-263, 1976.
8. Hedlund, H., Andersson, K.E. and E.K. A.: Effects of prazosin in patients with benign prostatic obstruction. J. Urol., 130, 275-278, 1983.
9. Lepor, H., Baumann, M. and Shapiro, E.: The alpha adrenergic binding properties of terazosin in the human prostate adenoma and canine brain. J. Urol., 140, 664-667, 1988.
10. Shapiro, E., Hartanto, V. and Lepor, H.: The response to alpha blockade in benign prostatic hyperplasia is related to the percent area density of prostate smooth muscle. The Prostate, 21, 297-307, 1992.
11. 1-blocker, YM617, in the treatment of benign prostatic hypertrophy. J. Urol., 144, 908-912, 1990.
12. Deering, R.E., Choongkittaworn, M., Bigler, S. A., Aramburu, E., King, J. and Brawer, M K.: Morphometric quantitation of stroma in human benign prostatic hyperplasia. Urology, 44, 64-70, 1994.
13. Shapiro, E., Hartanto, V. and Lepor, H.: Anti-desmin vs. anti-actin for quantifying the area density of prostate smooth muscle. The Prostate, 20, 259-267, 1992.
14. Shapiro, E., Hartanto, V. and Lepor, H.: Quantifying the smooth muscle content of the prostate using double-immunoenzymatic staining and color assisted image analysis. J. Urol., 147, 1167-1170, 1992.
15. Siegel, Y.I., Zaidel, L., Hammel. I., Korczak, D. and Lindner, A.: Morphometric evaluation of benign prostatic hyperplasia. Eur. Urol., 18, 71 -73, 1990.
16. Furuya, S., Kumamoto, Y., Yokoyama, E., Tukamoto, T., Izumi, T. and Abiko, Y.: Alpha-adrenergic activity and urethral pressure in prostatic zone in benign prostatic hypertrophy. J. Urol., 128, 836-839, 1982.
17. Kitada, S. and Kumazawa, J: Pharmacological characteristics of smooth muscle in benign prostatic hyperplasia and normal prostatic tissue. J. Urol , 138, 158-160, 1987.
18. Kitagawa, N., Ichikawa, T., Akimoto, S. and Shimazaki, J.: Nature course of human benign prostatic hyperplasia with relation to urinary disturbance. Prostate, 24, 279-284, 1994.
19. Shapiro, E., Becich, M.J., Hartanto, V. and Lepor, H.: The relative proportion of stromal and epithelial hyperplasia is related to the development of symptomatic benign prostate hyperplasia. J. Urol., 147, 1293-1297, 1992.
20. Yasuda, K., Yamanishi, T., Tojo, M., Nagashima, K., Akimoto, S. and Shimazaki, J.: Effect of naftopidil on urethral obstruction in benign prostatic hyperplasia: Assessment by urodynamic studies. Prostate, 25, 46-52, 1994.
21. Kawabe, K., Moriyama, N., Yamada, S. and Taniguchi, N.: Rationale for the use of α-blockers in the treatment of benign prostatic hyperplasia (BPH). Int. J. Urol., 1, 203-211, 1994.
22. 1 adrenoceptor antagonists on prostatic pressure and blood pressure in the anesthetized dog. Urology, 44, 52-57, 1994.
23. 1c subtype. Mol. Pharmacol., 45, 703-708, 1994.